D-dimero e TEV: i risultati dello studio Palladio
Di Nicoletta Riva | 6 Marzo 2018 | 0
Ultima modifica: 22 Dicembre 2023
Il D-dimero è un biomarker di tromboembolismo venoso (TEV) molto sensibile, ma aspecifico. Può...
CLOT+ RSS Feed- Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial.Circulation. 2026 Jan 6;153(1):21-34. doi: 10.1161/CIRCULATIONAHA.125.077232. Epub 2025 Nov 3.
- Outcomes of anticoagulation treatment for renal cell carcinoma tumor thrombi: a systematic review.J Thromb Haemost. 2025 Nov 4:S1538-7836(25)00720-2. doi: 10.1016/j.jtha.2025.10.020.
- Does the Combination of Anticoagulants and Angiogenesis Inhibitors Increase the Risk of Bleeding in Cancer Patients?.Thromb Haemost. 2025 Nov 28. doi: 10.1055/a-2740-1655.